Sohail Balasubramanian

Sohail Balasubramanian currently serves as the Senior Director of Corporate Business Development - Transactions and M&A at Eli Lilly and Company since October 2025. Prior experience includes roles as Director and Associate Director in Business Development at BioNTech SE, where significant accomplishments included negotiating a pivotal license agreement and managing multiple technology evaluations. Sohail's background also encompasses leadership positions at Jounce Therapeutics, Inc., Celsius Therapeutics, and Foundation Medicine, where expertise in M&A, licensing, and strategic alliances was demonstrated through successful negotiations and business growth initiatives. Educational qualifications include a Bachelor of Science in Cellular and Molecular Biology from the University of Michigan, a Master of Science in Biotechnology from Northeastern University, and an MBA focused on Health Sector, Innovation & Entrepreneurship from Boston University.